No in vivo molecular target

The term "No in vivo molecular target" is a classification used in pharmacological databases such as ChEMBL and DrugBank to identify therapeutic agents that do not interact with a specific protein, nucleic acid, or other biological macromolecule (ChEMBL Database, 2024). These agents typically exert their effects through non-specific chemical or physical mechanisms rather than through high-affinity binding to a receptor or enzyme active site (DrugBank Online, 2024). For instance, antacids like aluminum hydroxide work by direct chemical neutralization of gastric hydrochloric acid, while osmotic agents like mannitol create a physical osmotic gradient to move water across membranes (StatPearls, 2023). Because these substances lack a specific molecular target, they do not follow the traditional lock-and-key model of drug-target interactions. This designation is crucial for distinguishing between targeted therapies and agents that act on the bulk properties of physiological fluids or environments. In clinical practice, these agents are often used for symptomatic relief or as diagnostic aids, such as barium sulfate in medical imaging (PubChem, 2024). Understanding this classification helps biotech analysts identify drugs whose safety and efficacy profiles are governed by physical chemistry rather than molecular biology.

Other names

Non-molecular mechanismNo specific molecular targetNon-target mediated action

Chemical neutralization, osmotic effects, physical adsorption, or mechanical action